Home »
Academic Articles & Research Papers
Showing 16 of 16 academic articles
He H, Wang Q, Lu Y, Zhang Y et al. • Frontiers in medicine
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.3389/fmed.2026.1970456
PMC: PMC13730959
Guerrero-López CM, Serván-Mori E, Godínez-Alejandre J, Jan S et al. • International journal for equity in health
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1186/s12939-026-02873-4
PMC: PMC13737528
Adams M, Grieg C, Gonsiorek W, Wetterstrand C et al. • Inflammation and regeneration
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1186/s41232-026-00439-z
PMC: PMC13737601
Smith SL, Rossi S, Shukla R, Yap CF et al. • iScience
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1016/j.isci.2026.117949
PMC: PMC13734958
Malik F, Ahmed J, Shah M, Uttam R et al. • Mediterranean journal of rheumatology
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.31138/mjr.061225.ldt
PMC: PMC13583195
Chai Z, Wang M, Zheng J, Yu J • Frontiers in pharmacology
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.3389/fphar.2026.1939732
PMC: PMC13639663
Sun Y, Stradner MH, Fessler J, Reisch MK • RMD open
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1136/rmdopen-2026-007225
PMC: PMC13711596
Valentin Ritschl, Angelika Lackner, Carina Boström, Erika Mosor et al. • Arthritis Research & Therapy
(2018)
Abstract Background It is estimated that 50–70% of patients with rheumatoid arthritis (RA) are non-adherent to their recommended treatment. Non-adherent patients have a higher risk of not reaching an optimal clinical outcome. We explored fa...
DOAJ
Open Access (DOAJ)
DOI: 10.1186/s13075-018-1732-7
Sebastian Makuch, Kamil Więcek, Marta Woźniak • Pharmaceuticals
(2021)
Rheumatoid arthritis (RA) is a widespread chronic autoimmune disorder affecting the joints, causing irreversible cartilage, synovium, and bone degradation. During the course of the disease, many immune and joint cells are activated, causing...
DOAJ
Open Access (DOAJ)
DOI: 10.3390/ph14040309
Hamid Reza Rahimi, Mahmoud Reza Jaafari, Amir Hooshang Mohammadpour, Khalil Abnous et al. • Asia Pacific Journal of Medical Toxicology
(2015)
Alcoholic liver disease (ALD) is the main cause of chronic liver disease across the world and can lead to fibrosis and cirrhosis. The etiopathogenesis of ALD is related to ethanol-induced oxidative stress, glutathione reduction, abnormal me...
DOAJ
Open Access (DOAJ)
DOI: 10.22038/apjmt.2015.3983
Soo-Kyung Cho, Dam Kim, Dasomi Yoo, Eun Jin Jang et al. • Journal of Ginseng Research
(2018)
Background: Panax ginseng is a well-known immune modulator, and there is concern that its immune-enhancing effects may negatively affect patients with rheumatoid arthritis (RA) by worsening symptoms or increasing the risk of adverse effects...
DOAJ
Open Access (DOAJ)
DOI: 10.1016/j.jgr.2017.01.006
Lisa Argnani, Anna Zanetti, Anna Zanetti, Greta Carrara et al. • Frontiers in Medicine
(2021)
Background: Rheumatoid arthritis (RA) is associated with an increase in cardiovascular (CV) risk. This issue maybe not only explained by a genetic component, as well as by the traditional CV risk factors, but also by an underestimation and ...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fmed.2021.745601
Ya-Wen Peng, Ri Tang, Qiao-Yi Xu, Shu-Ya Mei et al. • Heliyon
(2024)
Background: Fibrosis is a heavy burden on the global healthcare system. Recently, an increasing number of studies have demonstrated that Extracellular vesicles play an important role in intercellular communication under both physiological a...
DOAJ
Open Access (DOAJ)
DOI: 10.1016/j.heliyon.2024.e24357
Guillaume Larid, Justine Vix, Ronan Garlantezec, Elodie Loppin et al. • Scientific Reports
(2022)
Abstract Remission in rheumatoid arthritis (RA) is an important therapeutic target that is not easy to achieve in real-life conditions. Some prognostic factors have been identified but the literature is variable. The objectives of this stud...
DOAJ
Open Access (DOAJ)
DOI: 10.1038/s41598-022-06584-y
Kai Zhao, Yujia Shi, Hon-Cheong So • Pharmaceutics
(2022)
Identification of the correct targets is a key element for successful drug development. However, there are limited approaches for predicting drug targets for specific diseases using omics data, and few have leveraged expression profiles fro...
DOAJ
Open Access (DOAJ)
DOI: 10.3390/pharmaceutics14020234
de Souza RM, Tuon FF, Nicodemo AC, Emori CT et al. • The American journal of tropical medicine and hygiene
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.4269/ajtmh.26-0345
PMC: PMC13590949